Article Details
Retrieved on: 2019-01-24 19:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>AQR Capital Management</b> LLC lessened its position in Endocyte, Inc. (NASDAQ:ECYT) by 28.7% in the third quarter, according to the company in its ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here